Cambridge Enterprise

Cambridge Enterprise, established in 1972, is a UK-based management consulting firm specializing in supporting the commercialization of intellectual property and spin-out companies from the University of Cambridge. It offers services such as confidentiality agreements, intellectual property management, liability assessment, venture building, investment facilitation, and contractual negotiation, primarily focusing on life science and medical technology sectors.

Chris Gibbs

Investment Director, Physical Sciences

James Thomas

Investor Board representative (Consultant)

Past deals in Intellectual Property

UpFront

Upfront Diagnostics is a healthcare company focused on the development of innovative blood biomarkers aimed at enhancing medical diagnosis, particularly for stroke patients experiencing large vessel occlusions. By enabling rapid and precise identification of this stroke subtype, Upfront Diagnostics' biomarkers facilitate quicker treatment decisions by clinicians, paramedics, and nurses. This timely intervention is crucial for improving patient outcomes, as it can significantly reduce the time to treatment, thereby minimizing disabilities and fatalities associated with strokes. The company holds a portfolio of patents that safeguard its proprietary biomarkers, underscoring its commitment to advancing stroke care and improving overall healthcare efficiency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.